Cocrystal Pharma's total assets for Q3 2024 were $16.23M, a decrease of -24.75% from the previous quarter. COCP total liabilities were $3.53M for the fiscal quarter, a -15.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.